Related Experiment Videos
Regulation of endogenous gene expression with a small-molecule dimerizer
Roy Pollock1, Maryann Giel, Katja Linher
1ARIAD Gene Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA. roy.pollock@ariad.com
Nature Biotechnology
|June 29, 2002
Summary
Researchers developed a novel method to control gene expression using artificial transcription factors. This system allows for precise, small-molecule-induced regulation of the human VEGF gene, offering a new tool for gene therapy research.
Area of Science:
- Molecular Biology
- Gene Regulation
- Synthetic Biology
Background:
- Designer zinc-finger DNA-binding domains (DBDs) are used to control endogenous gene expression.
- Small-molecule control systems offer precise regulation of biological processes.
Purpose of the Study:
- To develop a small-molecule-controlled system for regulating endogenous gene transcription.
- To engineer a dimerizer-responsive transcription factor targeting the human VEGF gene promoter.
Main Methods:
- Combined zinc-finger DBD technology with a dimerizer-regulated gene expression system.
- Constructed a dimerizer-responsive transcription factor targeting the human VEGF gene.
- Introduced the activator into human cells and induced expression with a small-molecule dimerizer.
Main Results:
- Achieved small-molecule-induced activation of the chromosomal human VEGF gene.
- Demonstrated that dimerizer-dependent VEGF induction was rapid, tight, and dose-dependent.
- Observed VEGF protein expression levels several-fold higher than the natural hypoxic response.
Conclusions:
- Directly regulating zinc-finger protein (ZFP) activity circumvents challenges with conventional activators.
- This novel system provides a powerful tool for precise control of endogenous gene transcription.
- The developed system shows potential for applications in gene therapy and functional genomics research.